News

Roche and Genentech have opened a new innovation center in Boston, Massachusetts, expanding their research and development presence in one of the world's major life sciences hubs.…
Read More...

Novo Nordisk has received a positive recommendation from the Committee for Medicinal Products for Human Use (CHMP) for the use of Sogroya in children with idiopathic short stature (ISS)…
Read More...

Novo Nordisk has received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) recommending marketing authorisation for FREHEMGO (denecimig) to treat…
Read More...

Roche has reported positive Phase 3 results for Lunsumio (mosunetuzumab) combined with lenalidomide in people with relapsed or refractory follicular lymphoma. The CELESTIMO study met…
Read More...

WuXi XDC has entered into an out-licensing agreement with Ona Therapeutics to support the development of a new antibody-drug conjugate (ADC) for treatment-resistant cancers. Under…
Read More...

Sling Therapeutics has raised $123 million in a Series C financing to advance linsitinib, an oral drug being developed for thyroid eye disease (TED). The financing was led by…
Read More...

Viatris has received approval from Japan’s Ministry of Health, Labour and Welfare for WAKIX (pitolisant) to treat excessive daytime sleepiness (EDS) linked to obstructive sleep apnea…
Read More...

Cellares has partnered with Taiwanese cell therapy company GenomeFrontier Therapeutics to evaluate automated manufacturing for GF-CART01, an investigational CAR-T cell therapy being…
Read More...

Novo Nordisk has partnered with artificial intelligence company Anthropic to use AI to speed up drug discovery, support research and improve software development across its…
Read More...

QurCan Therapeutics has entered into an exclusive research and collaboration agreement with Eli Lilly and Company to develop genetic medicine treatments for diseases affecting the…
Read More...

Gilead Sciences has signed a new agreement with the Pan American Health Organization (PAHO) to help expand access to twice-yearly lenacapavir for HIV prevention across Latin America and…
Read More...

Novo Nordisk has unveiled a major rebrand as it begins what the company describes as its next chapter, introducing the single name “Novo” and a new brand platform built around the…
Read More...

Schrödinger has launched a new biotechnology company, Tectora, to develop potential treatments for immunology and inflammatory diseases. The company was co-founded by Schrödinger, New…
Read More...

CordenPharma is investing €80 million to expand its sterile injectable manufacturing capabilities at its Caponago site near Milan, Italy. The long-term investment program includes…
Read More...

The U.S. Food and Drug Administration (FDA) has granted accelerated approval to Bayer’s HYRNUO (sevabertinib) as a first-line treatment for adults with locally advanced or metastatic…
Read More...

Encoded Therapeutics has raised $275 million in a new financing round to advance its genetic medicine programs for severe neurological disorders, including its lead candidate ETX101 for…
Read More...

Exegenesis Bio and Modalis Therapeutics have entered a research collaboration and license agreement to advance MDL-201, an experimental treatment candidate for Duchenne muscular…
Read More...

The U.S. Food and Drug Administration (FDA) has granted accelerated approval to AstraZeneca’s Etcamah (camizestrant) for certain adults with advanced breast cancer, expanding treatment…
Read More...

AtomVie Global Radiopharma (AtomVie) has officially opened a new radiopharmaceutical manufacturing facility in Hamilton, Ontario, marking a major expansion of its production…
Read More...

Aptar Pharma has partnered with Aceso Therapeutics to support the development of ACT-101, an antisense oligonucleotide (ASO) candidate being developed as a potential treatment for…
Read More...